Last reviewed · How we verify

NCT06274762

Visually Impaired Women Model-based Cancer Education and Breast Self-examination

Status unknown NA Last updated 23 February 2024
What this trial tests

NA trial testing Training and BSE application on a model in Breast Cancer Awareness and BSE in Visually Impaired Women in 90 participants. Status unknown.

Timeline
1 April 2024
Primary endpoint
31 March 2025
31 March 2025

Quick facts

Lead sponsorMarmara University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationnon randomized
Designcrossover
Maskingnone
Primary purposeprevention
Enrollment90
Start date1 April 2024
Primary completion31 March 2025
Estimated completion31 March 2025
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Marmara University

Who can join

Adults 20 to 69, female only, with Breast Cancer Awareness and BSE in Visually Impaired Women. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of our study was to raise awareness among visually impaired women, who are in the vulnerable group, about breast cancer, which ranks first among female cancers, and to teach breast self-examination.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Marmara University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06274762.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing